Article
Measurement-driven quantum evolution
Date
2014Author
Duran-Ramirez, V.M.
Martinez-Rios, A.
Guerrero-Viramontes, J.A.
Munoz-Maciel, J.
Pena-Lecona, F.G.
Selvas-Aguilar, R.
Anzueto-Sanchez, G.
Institutions
Abstract
A very simple method to obtain the refractive index of liquids by using a rectangular glass cell and a diffraction grating engraved by fs laser ablation on the inner face of one of the walls of the cell is presented. When a laser beam impinges normally on the diffraction grating, the diffraction orders are deviated when they pass through the cell filled with the liquid to be measured. By measuring the deviation of the diffraction orders, we can determine the refractive index of the liquid. " 2014 Optical Society of America.",,,,,,"10.1364/OE.22.029899",,,"http://hdl.handle.net/20.500.12104/42710","http://www.scopus.com/inward/record.url?eid=2-s2.0-84914694867&partnerID=40&md5=345959acd2dbe13b5dff0c3cf3259ee2",,,,,,"24",,"Optics Express",,"29899 29906",,"22",,"Scopus WOS",,,,,,,,,,,,"Measurement of the refractive index by using a rectangular cell with a fs-laser engraved diffraction grating inner wall",,"Article"
"39201","123456789/35008",,"Valle,Y. Departamento de Biologia Molecular y Genomica, Centro Universitario de Ciencias de la Salud, Instituto de Investigacion en Reumatologia y del Sistema Musculo Esqueletico, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.",,"Valle Y Padilla-Gutierrez JR Torres-Carrillo NM Ledezma-Lozano IY Corona-Sanchez EG Vazquez-Del Mercado M Rangel-Villalobos H Gamez-Nava JI Gonzalez-Lopez L Munoz-Valle JF",,"2010",,"Tumor necrosis factor-alpha (TNF-alpha) plays a central role in inflammation, and it has been directly implicated in the pathogenesis of rheumatoid arthritis (RA). TNF-alpha activity is mediated through TNFRI and TNFRII cell surface receptors, which act as physiological attenuators of TNF-alpha activity. We recruited 190 RA patients and 190 healthy subjects (HS) in order to associate the -383A>C TNFRI polymorphism with sTNFRI levels and DAS28 score in RA. In results, sTNFRI levels were higher in RA patients than HS (P = 0.04). The -383A>C TNFRI polymorphism did not show significant differences in both studied groups. However, in the RA group the sTNFRI levels were significantly elevated (P = 0.004) in A/A genotype carriers. In addition, the A/A genotype carriers had the higher DAS28 score than A/C genotype (P = 0.02). These data suggest that -383A>C TNFRI polymorphism is not a susceptibility marker in RA, whereas the increased levels of sTNFRI could reflect the clinical activity in RA patients.",,"Record Owner: From MEDLINE, a database of the U.S. National Library of Medicine.; Status: MEDLINE; Publishing Model: Journal available in: Print-Electronic Citation processed from: Internet; NLM Journal Code: 8206885, tdz; Registry Number/Name of Substance: 0 (Biological Markers). 0 (Receptors, Tumor Necrosis Factor, Type I). 0 (TNFRSF1A protein, human).; Entry Date: 20100429",,,,"10.1007/s00296-009-1049-6",,"1437-160X; 0172-8172","http://hdl.handle.net/20.500.12104/37422","http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med5&AN=19582456",,"English",,,,"5",,"Rheumatology international",,"655 659",,"30",,"MEDLINE",,,,"Index Medicus;Adult;Aged;Aged, 80 and over;Arthritis, Rheumatoid/di [Diagnosis];Arthritis, Rheumatoid/eh [Ethnology];Arthritis, Rheumatoid/ge [Genetics];Arthritis, Rheumatoid/im [Immunology];Biological Markers/bl [Blood];Case-Control Studies;Female;Gene Frequency;Genetic Association Studies;Genetic Predisposition to Disease;Humans;Male;Mexico/ep [Epidemiology];Middle Aged;Phenotype;Polymorphism, Genetic;Receptors, Tumor Necrosis Factor, Type I/bl [Blood];Receptors, Tumor Necrosis Factor, Type I/ge [Genetics];Risk Assessment;Risk Factors;Severity of Illness Index;Young Adult",,,,,,,,"The -383A>C TNFRI polymorphism is associated with soluble levels and clinical activity in rheumatoid arthritis.",,"Journal Article"
"39215","123456789/35008",,,,"Gómez Valle, José de Jesús",,"2011",,,,,,,,,,"1870-0063","http://hdl.handle.net/20.500.12104/37436","http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1870-00632011000200017&lng=es&nrm=iso&tlng=es; http://132.248.9.1:8991/F/T2YHQN5JKYSPCIP3SAPK3TB1KGTDDEFCSVNH496MXCXGEJUB2B-01905?func=full-set-set&set_number=025047&set_entry=000236&format=999",,"Español",,,,"16",,"Andamios: revista de investigación social",,"325-329",,"8",,"PERIODICA CLASE",,,,,,,,"Historia y filosofía de la política",,,"(Pre)textos para acercarnos a la política. Villarreal Cantú, Eduardo ; Martínez González, Víctor Hugo (coords.) (Pre)textos para el análisis político. Disciplinas, reglas y procesos. México","(Pre)textos para acercarnos a la política. Villarreal Cantú, Eduardo ; Martínez González, Víctor Hugo (coords.) (Pre)textos para el análisis político. Disciplinas, reglas y procesos. México: Facultad Latinoamericana de Ciencias Sociales (FLACSO)/Universidad Von Humboldt, 2010",,"journalArticle"
"39229","123456789/35008","Domínguez Gutiérrez, Silvia Universidad de Guadalajara",,"Domínguez Gutiérrez, Silvia Universidad de Guadalajara",,"2004",,,,,,,,,,"1665-109X",,"http://hdl.handle.net/20.500.12104/37450",,"Español",,,,"25",,"Sinéctica",,"28-29",,,,"CLASE",,,,,,,,"Educación básica",,"Aproximación social al profesor de primaria",,,,"journalArticle",
"39206","123456789/35008",,"Macias-Barragan,Jose. Institute for Molecular Biology and Gene Therapy, Department of Molecular Biology and Genomics, University of Guadalajara, Guadalajara, Mexico. armdbo@gmail.com.",,"Macias-Barragan J Sandoval-Rodriguez A Navarro-Partida J Armendariz-Borunda J",,"2010",,"BACKGROUND: Pirfenidone (PFD) is a molecule that exhibits antifibrotic properties in a variety of in vitro and animal models of lung, liver and renal fibrosis. These pathologies share many fibrogenic pathways with an abnormal fibrous wound-healing process; consequently, tissue repair and tissue regeneration-regulating mechanisms are altered. OBJECTIVE: To investigate the usefulness of PFD as an antifibrotic agent in clinical and experimental models of fibrotic disease. CONCLUSIONS: There is a growing understanding of the molecular effects of PFD on the wound healing mechanism, leading to novel approaches for the management of fibrosis in lung, liver and renal tissues. Although the optimum treatment for fibrosis remains undefined, it is possible that combined therapeutic regimens that include this wide-application molecule, pirfenidone, could offer a useful treatment for fibrotic disease.",,"Record Owner: From MEDLINE, a database of the U.S. National Library of Medicine.; Status: PubMed-not-MEDLINE; Publishing Model: Journal available in: Electronic Citation processed from: Internet; NLM Journal Code: 101464642; Other ID: Source: NLM. PMC2944211; Entry Date: 20110714",,,,"10.1186/1755-1536-3-16",,"1755-1536; 1755-1536","http://hdl.handle.net/20.500.12104/37427","http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=20809935",,"English",,,,,,"Fibrogenesis & tissue repair",,"16",,"3",,"MEDLINE",,,,,,,,,,,,"The multifaceted role of pirfenidone and its novel targets.",,"Journal Article"
"39196","123456789/35008",,"Rivera Vargas, María Isabel Universidad de Guadalajara",,"Rivera Vargas, María Isabel Universidad de Guadalajara",,"2004",,,,,,,,,,"0185-0601","http://hdl.handle.net/20.500.12104/37417",,,"Español",,,,"3",,"Comercio exterior",,"196-206",,"54",,"CLASE",,,,,,,,"Tecnología",,,,"Aprendizaje tecnológico en los proveedores de la industria electrónica, Guadalajara, México",,"journalArticle"
"39233","123456789/35008",,,,"Lépiz Ildefonso, Rogelio",,"2011",,,,,,,,,,"0187-7380","http://hdl.handle.net/20.500.12104/37454","http://www.scielo.org.mx/pdf/rfm/v34n4/v34n4a11.pdf; http://132.248.9.1:8991/F/QYBFCDEMMK86QP7AN8HS2AYCPJC21Q8TXQAKE7H5DVGALAVUKF-04456?func=full-set-set&set_number=029909&set_entry=000212&format=999",,"Español",,,,"4",,"Revista Fitotecnia Mexicana",,"291-292",,"34",,"PERIODICA",,,,"Fitotecnia",,,,,,,,"'Amapolo' y 'Mulato', nuevas variedades de frijol para el estado de Jalisco, México",,"journalArticle"
"39225","123456789/35008",,,,"Ramírez Rodríguez, Juan Carlos",,"2009",,,,,,,,,,"1405-9436","http://hdl.handle.net/20.500.12104/37446","http://132.248.9.1:8991/F/T2YHQN5JKYSPCIP3SAPK3TB1KGTDDEFCSVNH496MXCXGEJUB2B-06616?func=full-set-set&set_number=025047&set_entry=000565&format=999",,"Español",,,,"29",,"Revista de estudios de género",,"109 145",,"2",,"PERIODICA CLASE",,,,"Sociología de la sexualidad",,,,,,,"¿Nuevas generaciones, nuevas creencias?","¿Nuevas generaciones, nuevas creencias? Violencia de género y jóvenes",,"journalArticle"
"39202","123456789/35008",,"Alvarado-Navarro,Anabell. Centro de Investigacion en Inmunologia y Dermatologia, Departamento de Fisiologia, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.",,"Alvarado-Navarro A Montoya-Buelna M Munoz-Valle JF Lopez-Roa RI Guillen-Vargas C Fafutis-Morris M",,"2008",,"Leprosy is a chronic infectious disease caused by Mycobacterium leprae. IL-12 participates in the immune response against M. leprae by regulating T cell differentiation into the Th1-type response. Several single nucleotide polymorphisms have been identified in the IL-12 gene such as 3'UTR 1188 A/C polymorphism, which is associated with different diseases. However, the relationship of this polymorphism with the immune response in leprosy has not been explored. In this case-control study, we evaluated 44 patients with lepromatous leprosy (LL) and 51 healthy subjects (HS). We aimed to determine the relationship between 3'UTR 1188 A/C polymorphism of IL-12 p40, mRNA expression, and soluble IL-12 concentration in LL patients and HS. Genotype frequencies were 41% A/A, 36% A/C, and 23% C/C in LL patients, and 47% A/A, 49% A/C, and 4% C/C in HS (p<0.05). LL patients had a lower mRNA expression of IL-12 p40 gene, whereas HS had a higher expression level. Soluble IL-12 p40 concentration was higher in LL patients than in HS (p<0.05). IL-12 p70 concentration did not differ between groups, and IL-12 p40 concentration was not significantly correlated with mRNA expression in either group. These data suggest that IL-12 p40 3'UTR 1188 A/C polymorphism is associated with greater susceptibility to lepromatous leprosy in patients from western Mexico, independently of IL-12 p40 and p70 expression levels.",,"Record Owner: From MEDLINE, a database of the U.S. National Library of Medicine.; Status: MEDLINE; Publishing Model: Journal available in: Print-Electronic Citation processed from: Print; NLM Journal Code: 7910006, gih; Registry Number/Name of Substance: 0 (3' Untranslated Regions). 0 (Interleukin-12 Subunit p40). 0 (RNA, Messenger). 187348-17-0 (Interleukin-12).; Entry Date: 20081219",,,,"10.1016/j.imlet.2008.03.015",,"0165-2478; 0165-2478","http://hdl.handle.net/20.500.12104/37423","http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med5&AN=18485489",,"English",,,,"2",,"Immunology letters",,"148 151",,"118",,"MEDLINE",,,,"Index Medicus;3' Untranslated Regions/ge [Genetics];Adult;Aged;Case-Control Studies;Female;Gene Expression Regulation;Gene Frequency;Genetic Predisposition to Disease;Genotype;Humans;Interleukin-12/bl [Blood];Interleukin-12 Subunit p40/bl [Blood];Interleukin-12 Subunit p40/ge [Genetics];Leprosy, Lepromatous/ge [Genetics];Male;Mexico;Middle Aged;Polymorphism, Genetic;RNA, Messenger/me [Metabolism]",,,,,,,,"The 3'UTR 1188 A/C polymorphism in the interleukin-12p40 gene (IL-12B) is associated with lepromatous leprosy in the west of Mexico.",,"Journal Article"
"39211","123456789/35008",,"Ortiz, G.G., Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social. Guadalajara, Jalisco. México. Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara. Guadalajara, Jalisco. México. OPD Instituto Jalisciense de Cancerología. Guadalajara, Jalisco. México. Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara. Guadalajara. Jalisco. México. Centro Universitario Enrique Díaz de León, Guadalajara, Jalisco. México; Árias-Merino, E.D., Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social. Guadalajara, Jalisco. México. Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara. Guadalajara, Jalisco. México. OPD Instituto Jalisciense de Cancerología. Guadalajara, Jalisco. México. Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara. Guadalajara. Jalisco. México. Centro Universitario Enrique Díaz de León, Guadalajara, Jalisco. México; Velázquez-Brizuela, I.E., Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social. Guadalajara, Jalisco. México. Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara. Guadalajara, Jalisco. México. OPD Instituto Jalisciense de Cancerología. Guadalajara, Jalisco. México. Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara. Guadalajara. Jalisco. México. Centro Universitario Enrique Díaz de León, Guadalajara, Jalisco. México; Pacheco-Moisés, F.P., Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social. Guadalajara, Jalisco. México. Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara. Guadalajara, Jalisco. México. OPD Instituto Jalisciense de Cancerología. Guadalajara, Jalisco. México. Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara. Guadalajara. Jalisco. México. Centro Universitario Enrique Díaz de León, Guadalajara, Jalisco. México; Flores-Alvarado, L.J., Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social. Guadalajara, Jalisco. México. Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara. Guadalajara, Jalisco. México. OPD Instituto Jalisciense de Cancerología. Guadalajara, Jalisco. México. Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara. Guadalajara. Jalisco. México. Centro Universitario Enrique Díaz de León, Guadalajara, Jalisco. México; Torres-Sánchez, E.D., Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social. Guadalajara, Jalisco. México. Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara. Guadalajara, Jalisco. México. OPD Instituto Jalisciense de Cancerología. Guadalajara, Jalisco. México. Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara. Guadalajara. Jalisco. México. Centro Universitario Enrique Díaz de León, Guadalajara, Jalisco. México; Cortés-Enríquez, F., Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social. Guadalajara, Jalisco. México. Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara. Guadalajara, Jalisco. México. OPD Instituto Jalisciense de Cancerología. Guadalajara, Jalisco. México. Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara. Guadalajara. Jalisco. México. Centro Universitario Enrique Díaz de León, Guadalajara, Jalisco. México; González-Renovato, E.D., Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social. Guadalajara, Jalisco. México. Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara. Guadalajara, Jalisco. México. OPD Instituto Jalisciense de Cancerología. Guadalajara, Jalisco. México. Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara. Guadalajara. Jalisco. México. Centro Universitario Enrique Díaz de León, Guadalajara, Jalisco. México; Ortiz-Velázquez, I.G., Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social. Guadalajara, Jalisco. México. Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara. Guadalajara, Jalisco. México. OPD Instituto Jalisciense de Cancerología. Guadalajara, Jalisco. México. Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara. Guadalajara. Jalisco. México. Centro Universitario Enrique Díaz de León, Guadalajara, Jalisco. México",,"Ortiz, G.G. Arias-Merino, E.D. Velazquez-Brizuela, I.E. Pacheco-Moises, F.P. Flores-Alvarado, L.J. Torres-Sanchez, E.D. Cortes-Enriquez, F. Gonzalez-Renovato, E.D. Ortiz-Velazquez, I.G.",,"2012",,"Studies about the effects of aging in the physiology and metabolism are increasingly, one of its objectives is to help implement programs to improve the quality of life and prevent disability in elderly. It is relevant to mention that, during aging, there is a natural metabolic deceleration, a series of changes in the regulation of energy are produced, which contributes to loss of weight and fat; the changes in the regulation of caloric intake contribute to increase the susceptibility to energy imbalance both positive and negative, which is associated with a deterioration in health. However, to grow old, is not a death sentence for metabolism, on the other hand, it can be controlled by maintaining an active lifestyle, coupled with this, research has shown that the metabolism can be regulated by a synchronized clock (circadian rhythms), which is mediated by regulatory proteins, this relationship ensures the proper functioning of the cells and therefore good health. The aim of this review is to provide updated information on the energy-metabolism-regulation and its relationship with the great variety of components involved in energy expenditure that accompany aging, to analyze the regulation of this system to improve the quality of life and maintenance of health in old age.",,,,,,,,,"http://hdl.handle.net/20.500.12104/37432","http://www.scopus.com/inward/record.url?eid=2-s2.0-84876765274&partnerID=40&md5=2bbeba2d1d8246a880afbce9902b8bc7",,,,,,"3",,"Archivos Latinoamericanos de Nutricion",,"249 257",,"62",,"Nutrition & Dietetics WOS",,,,,,"Aging; Biological clock; Circadian rhythm; Energy expenditure; Metabolism regulatory factors",,,,,,"Aging and metabolism: Changes and regulation [Envejecimiento y metabolismo: Cambios y regulación]",,"Article"
"39228","123456789/35008",,,"Sosa, Rodrigo",,"2014",,"En el presente trabajo se explorá la posibilidad de que un estímulo relacionado con la ausencia de una recompensa primaria adquiriera una función aversiva en una situación de elección. Se expuso a ratas a una condición de elección entre dos alternativas: (1) la entrega de agua después de transcurrido un intervalo de demora, y (2) la presentación de un ruido blanco seguido de un tiempo fuera. De este modo, el ruido blanco fue un predictor negativo de la entrega de agua. La aversividad adquirida por el ruido blanco fue evaluada examinando la preferencia de los sujetos por una alternativa SS (i.e., entrega de agua inmediata con una menor magnitud) en la que se añadía el ruido blanco. En el Experimento 1 se utilizó un diseño mixto; es decir, se comparó la ejecución de los sujetos después del tratamiento experimental con su ejecución previa al tratamiento, y también se comparó su ejecución con sujetos en grupos de control. Los sujetos del Grupo Experimental mostraron una menor preferencia por la alternativa SS después de la Fase de Tratamiento comparada con su propia ejecución durante la Línea Base y comparada con la ejecución de los sujetos de control. Sin embargo, dichas diferencias no fueron estadísticamente significativas. En el Experimento 2 se incrementó el tamaño de la muestra y se utilizó un diseño entre grupos. Nuevamente, los sujetos del Grupo Experimental mostraron una menor preferencia por la alternativa SS que los sujetos de control. Sin embargo, este efecto podría ser interpretado mediante una explicación distinta a que el ruido blanco haya adquirido propiedades aversivas.",,,,,,,,"0188-8145",,"http://132.248.9.34/hevila/Actacomportamentalia/2014/vol22/no2/3.pdf; http://132.248.9.1:8991/F/T2YHQN5JKYSPCIP3SAPK3TB1KGTDDEFCSVNH496MXCXGEJUB2B-01783?func=full-set-set&set_number=025047&set_entry=000007&format=999 http://hdl.handle.net/20.500.12104/37449",,"Español",,,,"2",,"Acta comportamentalia",,"153 167",,"22",,"PERIODICA CLASE",,,,"Psicología experimental",,,,,,"Pueden estímulos relacionados con la ausencia de recompensa reducir la impulsividad en ratas?","Pueden estímulos relacionados con la ausencia de recompensa reducir la impulsividad en ratas?",,,"journalArticle",
"39197","123456789/35008",,"Trujillo-Contreras,F. Centro de Investigacion de Enfermedades Tropicales, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.",,"Trujillo-Contreras F Yerenas MA",,"1995",,"In 1987 the University of Guadalajara performed a seroepidemiological survey on the prevalence of Chagas disease in the 124 counties of the State of Jalisco, Mexico, arriving at a rate of 21.6 per 100 inhabitants. From December 1993 to June 1994, we studied 2238 individuals from 32 rural counties in this State. Of these, we found 276 positives (12.33%) and 1962 negatives (87.66%). Nevertheless, the series of serological differences found are very striking, since out of the 655 individuals that were seropositive in 1987, we noted that 276 individuals remained positive, while 50 individuals (7.63%) became negative. There were no flaws in the laboratory techniques. We believe that either the immune response of Mexicans is different or that the virulence of the Mexican strains of Trypanosoma cruzi may be not as great as that in the South America countries.",,"Record Owner: From MEDLINE, a database of the U.S. National Library of Medicine.; Status: PubMed-not-MEDLINE; Publishing Model: Journal available in: Print-Electronic Citation processed from: Print; NLM Journal Code: c4a, 8901573; Entry Date: 20050405",,,,,,"0102-311X; 0102-311X","http://hdl.handle.net/20.500.12104/37418","http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=12973630",,"English",,,,"3",,"Cadernos de Saude Publica",,"501 505",,"11",,"MEDLINE",,,,,,,,,,,,"Serological follow-up of Trypanosoma cruzi infection from 1987 to 1994 in 32 counties of the State of Jalisco, Mexico: preliminary report.",,"Journal Article"
"39219","123456789/35008",,,,"Cabrales Barajas, Luis Felipe",,"2010",,,,,,,,,,"0187-8611","http://hdl.handle.net/20.500.12104/37440","http://132.248.9.1:8991/F/T2YHQN5JKYSPCIP3SAPK3TB1KGTDDEFCSVNH496MXCXGEJUB2B-11116?func=full-set-set&set_number=025047&set_entry=000380&format=999",,"Español",,,,"85",,"Ciudades",,"59 62",,"21",,"PERIODICA CLASE",,,,"Sociología rural",,,,,,,"°Campo o ciudad?","°Campo o ciudad? el territorio como hipertexto. Arias, Patricia; Woo, Ofelia, (coordinadoras). °Campo o ciudad?. Nuevos espacios y formas de vida. México: Universidad de Guadalajara, 309 p.",,"journalArticle"
"39246","123456789/35008","Preciado Serrano, María de Lourdes Universidad de Guadalajara",,"Preciado Serrano, María de Lourdes Universidad de Guadalajara",,"2004",,,,,,,,,,"1405-7980",,"http://132.248.9.1:8991/F/1NSTK5CYVSV48SPM24TP4PL8LBSFK25CUAG5QAD7JNS5PIR4R5-02020?func=full-set-set&set_number=034002&set_entry=000650&format=999 http://hdl.handle.net/20.500.12104/37467",,"Español",,,,"2",,"Investigación en Salud (Universidad de Guadalajara)",,"91-96",,"6",,"PERIODICA",,,,,,,,"Salud pública",,"Agotamiento emocional: escala Burnout adaptada para mujeres trabajadoras en la costura industrial","Agotamiento emocional",,,"journalArticle",
"39244","123456789/35008",,"López Soto, José Luis Universidad de Guadalajara",,"López Soto, José Luis Universidad de Guadalajara",,"2005",,,,,,,,,,"0187-7380","http://hdl.handle.net/20.500.12104/37465","http://132.248.9.1:8991/F/1NSTK5CYVSV48SPM24TP4PL8LBSFK25CUAG5QAD7JNS5PIR4R5-20890?func=full-set-set&set_number=034002&set_entry=000592&format=999",,"Español",,,,"3",,"Revista Fitotecnia Mexicana",,"221-230",,"28",,"PERIODICA",,,,,,,,"Leguminosas",,,,"Adaptación climética de 25 especies de frijol silvestre (Phaseolus spp) en la República Mexicana",,"journalArticle"
"39203","123456789/35008",,"García-Gonzalez,Ilian Janet. Instituto de Investigacion en Ciencias Biomedicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, Mexico ; Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, Mexico. Valle,Yeminia. Instituto de Investigacion en Ciencias Biomedicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, Mexico. Sandoval-Pinto,Elena. Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, Mexico. Valdes-Alvarado,Emmanuel. Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, Mexico. Valdez-Haro,Angelica. Instituto de Investigacion en Ciencias Biomedicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, Mexico ; Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, Mexico. Munoz-Valle,Jose Francisco. Instituto de Investigacion en Ciencias Biomedicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, Mexico. Flores-Salinas,Hector Enrique. Centro Medico Nacional de Occidente, IMSS, 44350 Guadalajara, JAL, Mexico. Figuera-Villanueva,Luis Eduardo. Centro de Investigacion Biomedica de Occidente, IMSS, 44350 Guadalajara, JAL, Mexico. Davalos-Rodriguez,Nory Omayra. Instituto de Investigacion en Genetica Humana, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, Mexico. Padilla-Gutierrez,Jorge Ramon. Instituto de Investigacion en Ciencias Biomedicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, Mexico.",,"García-Gonzalez IJ Valle Y Sandoval-Pinto E Valdes-Alvarado E Valdez-Haro A Munoz-Valle JF Flores-Salinas HE Figuera-Villanueva LE Davalos-Rodriguez NO Padilla-Gutierrez JR",,"2015",,"BACKGROUND: Acute coronary syndrome (ACS) has an important impact in public health with high morbidity and mortality. Prothrombotic and proinflammatory states are involved in the pathogenesis of the disease. Plasminogen activator inhibitor-1 (PAI-1) is the major inhibitor of the fibrinolysis and also is part of immune response. The -844 G>A gene polymorphism is related to increased PAI-1 protein levels. The aim of the study is to evaluate the association of -844 G>A PAI-1 polymorphism with ACS. METHODS: A total of 646 individuals were recruited from Western Mexico: 350 unrelated healthy subjects and 296 patients with diagnosis of ACS. RESULTS: The most important risk factor in our population was hypertension, followed by smoking. The genetic distribution showed an association of the A allele (OR = 1.27, P = 0.04) and AA genotype (OR = 1.86, P = 0.02) with ACS. The recessive model displayed similar results (OR = 1.76, P = 0.02). As additional finding, we observed significant differences in the genetic distribution of ACS dyslipidemic patients (OR = 1.99, P = 0.04). The A allele and AA genotype of -844 polymorphism of PAI-1 gene are risk factors for ACS. The AA genotype might be associated with the development of dyslipidemia in ACS patients.",,"Record Owner: From MEDLINE, a database of the U.S. National Library of Medicine.; Status: In-Process; Publishing Model: Journal available in: Print-Electronic Citation processed from: Internet; NLM Journal Code: dim, 8604127; Other ID: Source: NLM. PMC4350946",,,,"10.1155/2015/460974",,"1875-8630; 0278-0240","http://hdl.handle.net/20.500.12104/37424","http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=25788758",,"English",,,,,,"Disease markers",,"460974",,"2015",,"MEDLINE",,,,"Index Medicus",,,,,,,,"The -844 G>A PAI-1 polymorphism is associated with acute coronary syndrome in Mexican population.",,"Journal Article"
"39198","123456789/35008",,"Ramos-Loyo,Julieta. Instituto de Neurociencias, CUCBA, Universidad de Guadalajara, 44130 Guadalajara, JAL, Mexico.",,"Ramos-Loyo J Mora-Reynoso L Sanchez-Loyo LM Medina-Hernandez V",,"2012",,"The purpose of the present study was to determine sex differences in facial, prosodic, and social context emotional recognition in schizophrenia (SCH). Thirty-eight patients (SCH, 20 females) and 38 healthy controls (CON, 20 females) participated in the study. Clinical scales (BPRS and PANSS) and an Affective States Scale were applied, as well as tasks to evaluate facial, prosodic, and within a social context emotional recognition. SCH showed lower accuracy and longer response times than CON, but no significant sex differences were observed in either facial or prosody recognition. In social context emotions, however, females showed higher empathy than males with respect to happiness in both groups. SCH reported being more identified with sad films than CON and females more with fear than males. The results of this study confirm the deficits of emotional recognition in male and female patients with schizophrenia compared to healthy subjects. Sex differences were detected in relation to social context emotions and facial and prosodic recognition depending on age.",,"Record Owner: From MEDLINE, a database of the U.S. National Library of Medicine.; Status: PubMed-not-MEDLINE; Publishing Model: Journal available in: Print-Electronic Citation processed from: Internet; NLM Journal Code: 101576450; Other ID: Source: NLM. PMC3420677; Entry Date: 20120913",,,,"10.1155/2012/584725",,"2090-2093; 2090-2093","http://hdl.handle.net/20.500.12104/37419","http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=22970365",,"English",,,,,,"Schizophrenia Research & Treatment Print",,"584725",,"2012",,"MEDLINE",,,,,,,,,,,,"Sex differences in facial, prosodic, and social context emotional recognition in early-onset schizophrenia.",,"Journal Article"
"39216","123456789/35008",,,,"Valdez Zepeda, Andrés",,"2006",,,,,,,,,,"0187-8190","http://hdl.handle.net/20.500.12104/37437","http://132.248.9.1:8991/F/T2YHQN5JKYSPCIP3SAPK3TB1KGTDDEFCSVNH496MXCXGEJUB2B-09718?func=full-set-set&set_number=025047&set_entry=000836&format=999",,"Español",,,,"99",,"Revista mexicana de comunicación",,"19 24",,"18",,"PERIODICA CLASE",,,,"Historia política",,,,,,,,"ZapotitlánAl diablo las encuestas!",,"journalArticle"
"44490","123456789/35008",,"Roa, L., Center for Quantum Optics and Quantum Information, Departamento de Física, Universidad de Concepción, Casilla 160-C, Concepción, Chile; Delgado, A., Center for Quantum Optics and Quantum Information, Departamento de Física, Universidad de Concepción, Casilla 160-C, Concepción, Chile; Ladrón De Guevara, M.L., Center for Quantum Optics and Quantum Information, Departamento de Física, Universidad de Concepción, Casilla 160-C, Concepción, Chile, Departamento de Física, Universidad Católica Del Norte, Casilla 1280, Antofagasta, Chile; Klimov, A.B., Departamento de Física, Universidad de Guadalajara, Revolución 1500, 44420 Guadalajara, Jalisco, Mexico Klimov, Andrei B., Universidad de Guadalajara. Centro Universitario de Ciencias Exactas e Ingenierías",,"Roa, L. Delgado, A. Ladron De Guevara, M.L. Klimov, Andrei B.",,"2006",,"We study the problem of mapping an unknown mixed quantum state onto a known pure state without the use of unitary transformations. This is achieved with the help of sequential measurements of two noncommuting observables only. We show that the overall success probability is maximized in the case of measuring two observables whose eigenstates define mutually unbiased bases. We find that for this optimal case the success probability quickly converges to unity as the number of measurement processes increases and that it is almost independent of the initial state. In particular, we show that to guarantee a success probability close to one the number of consecutive measurements must be larger than the dimension of the Hilbert space. We connect these results to quantum copying, quantum deleting, and entanglement generation. " 2006 The American Physical Society.